US court reverses $482 million case against JNJ's Cordis
April 04, 2013 at 13:47 PM EDT
WASHINGTON, April 4 (Reuters) - Cordis Corp, a Johnson and Johnson subsidiary, did not infringe upon a stent patent owned by a radiologist, an appeals court said on Thursday, reversing a ruling by a lower court which had ordered Cordis to pay $482 million.
